- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT05799586
Préservation de la santé de la MTC pour la dépression (TCMHPFD)
Intervention de préservation de la santé en médecine traditionnelle chinoise pour la dépression : un essai contrôlé randomisé pilote
This study aims to evaluate the feasibility and preliminary effects of Traditional Chinese Medicine (TCM) health preservation for depression on depressive symptoms reduction and other health-related outcomes among Hong Kong Chinese adults with depression. Participants in intervention group will receive TCM health preservation course for six weeks (6 sessions, 2 hours each) and practice TCM health preservation during the 6-week follow-up period. Participants in the control group (waitlist control) will receive usual care. After the follow-up assessment, TCM health preservation courses for depression will be provided to them for compensation.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
Hong Kong, Hong Kong
- School of Nursing, the Hong Kong Polytechnic University
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Hong Kong Chinese adults aged 18-years-old to 65-years-old;
- diagnosed with moderate level of depression (a score of 10~20), evaluated by the Patient Health Questionnaire-9 (PHQ-9);
- can communicate in spoken Cantonese and written Chinese;
- willing to provide written informed consent and be able to adhere to the study protocol.
Exclusion Criteria:
- being pregnant or during the lactation, or plan to get pregnant;
- new onset or change of antidepressant medication or dosage in the last 3 months;
- PHQ-9 score≥20, meaning a severe level of depression;
- with a previous or present diagnosis of psychotic disorders as screened by the Chinese version of the Structured Clinical Interview for DSM-IV;
- the score of Hong Kong Montreal Cognitive Assessment less than 22;
- significant suicidal risk as rated by the Hamilton Depression Rating Scale item on suicide (score ≥3);
- with diagnosis of illness which can interfere the individuals to participate or adhere to the modified lifestyle;
- with diagnosis of medical conditions, which are not suitable to modify diet or do physical activities recommended by physicians;
- joining in another clinical trial during the study period;
- with any major medical condition that causes depression based on the judgement of the investigator.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: traditional Chinese medicine health preservation group
The participants in the traditional Chinese medicine health preservation group will attend six traditional Chinese medicine health preservation courses (2h each per one, for 6 weeks) to learn and experience traditional Chinese medicine health preservation from a registered traditional Chinese medicine practitioner in a classroom at the School Nursing, the Hong Kong Polytechnic University. Each class will be conducted in a small group of 4 to 6 participants to enhance interaction and ensure the quality of teaching. Participants will then practice traditional Chinese medicine health preservation at home for 6 weeks. |
The traditional Chinese medicine health preservation intervention for depression was developed based on a previous systematic review and meta-analysis of Traditional Chinese medicine based integrated health interventions for depression, traditional Chinese medicine health preservation textbooks, clinical practice guidelines related to traditional Chinese medicine health preservation and traditional Chinese medicine treatment for depression. The content and structure of traditional Chinese medicine health preservation for depression was achieved among Hong Kong traditional Chinese medicine experts via a Delphi study. Usual care |
|
Aucune intervention: Waitlist control group
Participants in the waitlist control group will receive usual care during the 6-week waitlist period of intervention, and 6-week waitlist period of follow-up. After the follow-up assessment, they will be provided an equivalent traditional Chinese medicine health preservation for depression. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in the Patient Health Questionnaire (PHQ-9)
Délai: Time Frame: Baseline, week 2, week 4, week 6, week 8, week 12
|
The PHQ-9, a self-rated questionnaire to assess the presence and severity of depressive symptoms of an individual during the last 2 weeks on a scale of 0 (not at all) to 3 (nearly every day), with a total score ranging from 0 to 27. A higher score indicates a higher severity of depression symptoms. |
Time Frame: Baseline, week 2, week 4, week 6, week 8, week 12
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in the Generalized Anxiety Disorder-7 (GAD-7)
Délai: Time Frame: Baseline, week 2, week 4, week 6, week 8, week 12
|
The GAD-7 is a four-point Likert scale for identifying probable cases of GAD and assess the severity of symptoms of GAD for the past 2 weeks. The total score of GAD-7 varies from 0 to 21, and responses include "nearly every day," "more than half the days," "several days", and "not at all". The cutoff point of 5, 10, and 15 of GAD-7 might be interpreted as showing mild, moderate, and severe levels of anxiety. Higher scores indicate more severe GAD symptoms. |
Time Frame: Baseline, week 2, week 4, week 6, week 8, week 12
|
|
Change in the Perceived Stress Scale (PSS-10)
Délai: Time Frame: Baseline, week 2, week 4, week 6, week 8, week 12
|
The PSS-10 is a 10-item scale that is often used for measuring perceived psychological stress. Each item is rated on a 5-point Liket scale during the past month, referring to "4" as "very often" and "0" as never. The total score changes from 0 to 40, with a higher score meaning a higher perceived psychological stress level. |
Time Frame: Baseline, week 2, week 4, week 6, week 8, week 12
|
|
Change in the Insomnia Severity Index (ISI)
Délai: Time Frame: Baseline, week 2, week 4, week 6, week 8, week 12
|
The ISI is a seven-item self-rating scale to assess the severity of insomnia, distress, and functional impairment associated with insomnia on a 5-point Likert scale. The score of each item of ISI ranges from 0 (no problem) to 4 (very severe problem), and the total score is interpreted as below: absence of insomnia as 0 to 7, sub-threshold insomnia as 8 to14, moderate insomnia as 15 to 21, and severe insomnia as 22 to 28. |
Time Frame: Baseline, week 2, week 4, week 6, week 8, week 12
|
|
Change in the Fatigue Assessment Scale (FAS)
Délai: Time Frame: Baseline, week 2, week 4, week 6, week 8, week 12
|
The FAS is a 10-item scale that evaluates symptoms of chronic fatigue with a five-point Likert-type scale, which ranges from 1 ("never") to 5 ("always"). A higher score means greater fatigue severity. The total score ranges from 10 to 50. A total FAS score < 22 means no fatigue, a score≥ 22 refers to fatigue. |
Time Frame: Baseline, week 2, week 4, week 6, week 8, week 12
|
|
Change in the Short-Form (six-dimension) Health Survey (SF-6D)
Délai: Time Frame: Baseline, week 6, week 8, week 12
|
The SF-6D covers six domains using a scale of 1 to 6 to evaluate participants' general health and quality of life. Higher scores indicate better health status. |
Time Frame: Baseline, week 6, week 8, week 12
|
|
Change in the General Self-Efficacy Scale (GSE)
Délai: Time Frame: Baseline, week 2, week 4, week 6, week 8, week 12
|
The GSE scale is a four-point Likert scale with ten items appropriate for evaluating an individual's self-efficacy. It is scored ranging from 1 point to 4 points, referring to "not at all true" to "exactly true" and the total score varied from 10 to 40. A higher score shows a more satisfactory self-efficacy. |
Time Frame: Baseline, week 2, week 4, week 6, week 8, week 12
|
|
Change in the Health-Promoting Lifestyle Profile II (HPLP II)
Délai: Time Frame: Baseline, week 4, week 6, week 8, week 12
|
The HPLP II is a scale with 52 items and 6 domains for measuring health-promoting behavior, defined as a multidimensional pattern of self-initiated perceptions and actions that serve to maintain or increase the level of self-actualization, wellness, and fulfillment of a person. The total scores of HPLP-II varies from 52 to 208. Higher HPLP II score denotes better level of health-promoting lifestyle. |
Time Frame: Baseline, week 4, week 6, week 8, week 12
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in the Credibility/ Expectancy Questionnaire (CEQ)
Délai: Time Frame: Baseline, week 6
|
The CEQ is a self-reported scale with 6 items and two subscales of treatment credibility and outcome expectancy to measure the participants' treatment credibility and outcome expectancy for improvement. The final scoring of the CEQ is computed by the sum of the items composing each subscale, with a higher quotation referring to higher treatment credibility and outcome expectation. The CEQ taps on participants' affective and cognitive evaluations of treatment satisfaction, credibility, and expectation. The subscale of credibility assesses beliefs about the treatment strength. The expectancy subscale assesses how participants perceive their symptoms will improve during the intervention period. |
Time Frame: Baseline, week 6
|
Collaborateurs et enquêteurs
Parrainer
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- TCMHPFD
- No.21B2/004A (Autre subvention/numéro de financement: the Chinese Medicine Development Fund, Hong Kong Special Administrative Region, China)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
The individual participant data will be available when the study has been published. The individual participant data will be available upon request.
Délai de partage IPD
No time restriction for the data availability
Critères d'accès au partage IPD
The individual participant data will be available upon request
Type d'informations de prise en charge du partage d'IPD
- PROTOCOLE D'ÉTUDE
- SÈVE
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .